Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer
CNBC | Biotech giant Regeneron said it aims to have doses of a potential drug for COVID-19 ready to start human clinical trials by early summer.
CNBC | Biotech giant Regeneron said it aims to have doses of a potential drug for COVID-19 ready to start human clinical trials by early summer.
Leave a Reply